Race-Based Medicine is Bad Medicine

10.20.2020 - By Genotypecast with Grey Genetics

Download our free app to listen on your phone

Elizabeth Fieg, MS, CGC expands on her recent Twitter thread, discussing the problems with using categories of race and ancestry to guide test selection in pharmacogenomics and more broadly in medical genetics. She explains how a broader approach to testing is more equitable and can also be more cost-effective.

Related Articles and Resources:
Follow Elizabeth on Twitter: @ElizFiegCGC
Elizabeth’s twitter thread on race and pharmacogenomics
Elizabeth’s interview for the AliveAndKickin podcast (09/30/20)
Brigham and Women’s Hospital’s Pharmacogenomics Clinic
Yudell M, et al. “NIH must confront the use of race in science.” Science  11 Sep 2020: Vol. 369, Issue 6509, pp. 1313-1314
Vyas DA, et al. “Hidden in Plain Sight — Reconsidering the Use of Race Correction in Clinical Algorithms.” August 27, 2020. New England Journal of Medicine. 2020; 383:874-882

Do you have questions or topics you’d like a genetic counselor to discuss on a future episode ?
Leave us a short voice message here! We may use your message on a future show. You can also email us at [email protected]

Are you looking for genetic counseling?
Grey Genetics is an independent telehealth genetic counseling and consulting company. Book an appointment with a genetic counselor specialized in your area of concern. All genetic counseling appointments take place over secure, HIPAA-compliant video-conferencing or by phone.
Grey Genetics on Twitter: @GreyGenetics
Grey Genetics on Instagram: @greygenetics
Grey Genetics on Facebook
Grey Genetics on LinkedIn

More episodes from Genotypecast with Grey Genetics